104 related articles for article (PubMed ID: 9434470)
21. [Progress in therapy for and diagnosis of diabetic neuropathies].
Baba M
Nihon Naika Gakkai Zasshi; 2009 Apr; 98(4):779-86. PubMed ID: 19472531
[No Abstract] [Full Text] [Related]
22. Changes in erythrocyte sorbitol concentrations measured using an improved assay system in patients with diabetic complications and treated with aldose reductase inhibitor.
Hayashi R; Hayakawa N; Makino M; Nagata M; Kakizawa H; Uchimura K; Hamada M; Aono T; Fujita T; Shinohara R; Nagasaka A; Itoh M
Diabetes Care; 1998 Apr; 21(4):672-3. PubMed ID: 9571366
[No Abstract] [Full Text] [Related]
23. Aldose reductase inhibitors and their potential for the treatment of diabetic complications.
Tomlinson DR; Stevens EJ; Diemel LT
Trends Pharmacol Sci; 1994 Aug; 15(8):293-7. PubMed ID: 7940997
[TBL] [Abstract][Full Text] [Related]
24. Inhibitory effects of Ganoderma applanatum on rat lens aldose reductase and sorbitol accumulation in streptozotocin-induced diabetic rat tissues.
Jung SH; Lee YS; Shim SH; Lee S; Shin KH; Kim JS; Kim YS; Kang SS
Phytother Res; 2005 Jun; 19(6):477-80. PubMed ID: 16114079
[TBL] [Abstract][Full Text] [Related]
25. Erythrocyte sorbitol level as a predictor of the efficacy of epalrestat treatment for diabetic peripheral polyneuropathy.
Ando H; Takamura T; Nagai Y; Kaneko S;
J Diabetes Complications; 2006; 20(6):367-70. PubMed ID: 17070440
[TBL] [Abstract][Full Text] [Related]
26. Erythrocytic sorbitol contents in diabetic patients correlate with blood aldose reductase protein contents and plasma glucose levels, and are normalized by the potent aldose reductase inhibitor fidarestat (SNK-860).
Asano T; Saito Y; Kawakami M; Yamada N; Sekino H; Hasegawa S;
J Diabetes Complications; 2004; 18(6):336-42. PubMed ID: 15531183
[TBL] [Abstract][Full Text] [Related]
27. Focus on molecules: aldose reductase.
Anil Kumar P; Bhanuprakash Reddy G
Exp Eye Res; 2007 Dec; 85(6):739-40. PubMed ID: 16997295
[No Abstract] [Full Text] [Related]
28. Fidarestat. Sanwa Kagaku/NC Curex/Sankyo.
Giannoukakis N
Curr Opin Investig Drugs; 2003 Oct; 4(10):1233-9. PubMed ID: 14649216
[TBL] [Abstract][Full Text] [Related]
29. [Imidazolidine/thiazolidine-acetate aldose reductase inhibitors].
Fresneau P
Ann Pharm Fr; 2000 Dec; 58(6):392-404. PubMed ID: 11148374
[TBL] [Abstract][Full Text] [Related]
30. Aldose reductase inhibitors.
Kirchain WR; Rendell MS
Pharmacotherapy; 1990; 10(5):326-36. PubMed ID: 2122421
[TBL] [Abstract][Full Text] [Related]
31. A selective aldose reductase inhibitor of a new structural class prevents or reverses early retinal abnormalities in experimental diabetic retinopathy.
Sun W; Oates PJ; Coutcher JB; Gerhardinger C; Lorenzi M
Diabetes; 2006 Oct; 55(10):2757-62. PubMed ID: 17003340
[TBL] [Abstract][Full Text] [Related]
32. [Progress in diagnosis of and therapy for diabetic polyneuropathies].
Baba M
Nihon Naika Gakkai Zasshi; 2004 Aug; 93(8):1556-62. PubMed ID: 15384682
[No Abstract] [Full Text] [Related]
33. [Diabetic complication].
Iwamoto Y
Nihon Rinsho; 1991 Sep; 49(9):2136-40. PubMed ID: 1960879
[No Abstract] [Full Text] [Related]
34. [Development of therapeutic agents for diabetic neuropathies].
Nakamura J
Nihon Rinsho; 2005 Jun; 63 Suppl 6():614-21. PubMed ID: 15999780
[No Abstract] [Full Text] [Related]
35. Molecule of the month. Ruboxistaurin mesilate hydrate.
Drug News Perspect; 2003 Dec; 16(10):691. PubMed ID: 14747848
[No Abstract] [Full Text] [Related]
36. The effects of zenarestat, an aldose reductase inhibitor, on peripheral neuropathy in Zucker diabetic fatty rats.
Shimoshige Y; Ikuma K; Yamamoto T; Takakura S; Kawamura I; Seki J; Mutoh S; Goto T
Metabolism; 2000 Nov; 49(11):1395-9. PubMed ID: 11092500
[TBL] [Abstract][Full Text] [Related]
37. [Significance of aldose-reductase inhibition with traditional Chinese and Western drugs in the treatment of diabetic peripheral neuropathy].
Liang X; Guo S
Zhongguo Zhong Xi Yi Jie He Za Zhi; 1999 Jul; 19(7):442-4. PubMed ID: 11783220
[No Abstract] [Full Text] [Related]
38. The pharmacology of diabetic complications.
Altan VM
Curr Med Chem; 2003 Aug; 10(15):1317-27. PubMed ID: 12871132
[TBL] [Abstract][Full Text] [Related]
39. Diabetic complications in lens and nerve and their prevention by sulindac or sorbinil: two novel aldose reductase inhibitors.
Jacobson M; Sharma YR; Cotlier E; Hollander JD
Invest Ophthalmol Vis Sci; 1983 Oct; 24(10):1426-9. PubMed ID: 6413448
[TBL] [Abstract][Full Text] [Related]
40. [Treatment of diabetic neuropathy].
Frati-Munari AC; Ariza-Andraca CR
Gac Med Mex; 1998; 134(1):85-92. PubMed ID: 9658700
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
